Table 4.
Drinking-Related, Relationship, and Psychological Symptom Outcome Variables Across Time for the SUD-PTSD and the SUD-only Groups
| Mean Score (SD) | Time
(w/in subjects) |
Group
(B/W subjects) |
Time x Group | |||||
|---|---|---|---|---|---|---|---|---|
| Outcome Measures | df (2,72) | df (1,36) | df (2,72) | |||||
| PTSD | Comparison | F | p | F | p | F | p | |
| Drinking Related Outcomes | ||||||||
| Percent Days Abstinenta | 48.41 | <.001 | 2.49 | .123 | 0.06 | .878 | ||
| Pretreatment | 36.77 (32.26) | 45.53 (36.05) | ||||||
| Posttreatment | 88.13 (26.77) | 99.71 (0.74) | ||||||
| 12M Follow-Up | 77.75 (30.96) | 85.66 (20.20) | ||||||
| DrInC Past 90 Days Total | 28.10 | <.001 | 0.12 | .735 | 0.83 | .410 | ||
| Pretreatment | 43.37 (31.06) | 39.21 (29.61) | ||||||
| Posttreatment | 7.47 (16.06) | 0.83 (2.50) | ||||||
| 12M Follow-Up | 10.84 (19.71) | 16.74 (28.66) | ||||||
| Relationship Functioning | ||||||||
| Dyadic Adjustment Scale | 6.55 | .004 | 1.96 | .170 | 0.15 | .825 | ||
| Pretreatment | 90.74 (19.62) | 98.53 (20.30) | ||||||
| Posttreatment | 102.19 (21.10) | 111.24 (16.69) | ||||||
| 12M Follow-Up | 97.26 (16.18) | 102.68 (25.81) | ||||||
| CTS Frequency of M to F Violenceb | 7.22 | .012 | .003 | .956 | 0.10 | .749 | ||
| Pretreatment | 7.26 (13.59) | 6.21 (14.79) | ||||||
| Posttreatment | NA | NA | ||||||
| 12M Follow-Up | 0.50 (1.15) | 1.19 (2.76) | ||||||
| Psychological Symptoms | ||||||||
| SCL-90-R Total Score | 9.19 | .001 | 1.92 | .175 | 1.31 | .274 | ||
| Pretreatment | 75.32 (70.30) | 64.16 (49.31) | ||||||
| Posttreatment | 63.35 (66.46) | 30.89 (32.73) | ||||||
| 12M Follow-Up | 55.42 (66.42) | 31.85 (31.28) | ||||||
Note. Group by Time repeated measures ANOVAs assessed treatment effects by group (SUD-PTSD or SUD-only) over time (pre, post, 1-year follow-up). Missing data (for fewer than 10% of cases at post and 20% at 12-month) was substituted with collateral partner data when available, or with a group mean score at the post period, or the score from the closest adjacent time period for 12-month.
Percentage days abstinent from the TLFB is given for the year before BCT, the pre- to post-treatment interval, and the year after BCT.
The CTS scores, which reflect the year before and the year after BCT, were only measured at baseline and 12-month follow-up. Therefore there is not a post score and the ANOVA examined only 2 time periods.